Sucralose

What It Is

Sucralose is a synthetic high-intensity sweetener made by selectively replacing three hydroxyl groups on a sucrose molecule with chlorine atoms. It is roughly 600 times sweeter than table sugar and is sold most widely under the brand name Splenda. It is the sweetener in this collection with the strongest formal regulatory clearance in the United States — and, as it happens, the one where two major regulators currently disagree with each other in public, on two separate questions.

Regulatory Status

Sucralose is the only sweetener covered on this site that went through the full US food additive petition process rather than a GRAS notification. It is codified at 21 CFR 172.831. FDA approved it for 15 food categories in 1998 and as a general-purpose sweetener in 1999, having reviewed more than 110 studies covering reproductive and nervous system effects, carcinogenicity and metabolism.

That distinction is worth understanding. A GRAS notification is a manufacturer’s own safety conclusion that FDA reviews and declines to question — the response letters say so explicitly. A food additive approval is FDA’s own affirmative determination, codified in regulation. Sucralose has the latter. Allulose, monk fruit and stevia have the former.

In the EU, sucralose is authorised as E 955. EFSA completed a re-evaluation adopted on 10 December 2025 and published in February 2026, concluding that no safety concerns arose regarding the genotoxicity of sucralose or its impurities and degradation products, and that existing authorised uses do not exceed the acceptable daily intake.

The ADI Disagreement

Regulators do not agree on how much sucralose is acceptable per day, and the gap is threefold:

• FDA: 5 mg per kg of body weight per day
• EFSA: 15 mg/kg bw/day — reconfirmed in the 2025 re-evaluation, derived from a benchmark dose reference point of 55 mg/kg bw/day
• JECFA (the joint FAO/WHO expert committee): 15 mg/kg bw/day

This reflects different risk-assessment conventions rather than a factual dispute about the underlying studies, but the practical consequence is real: any statement of “the ADI for sucralose” is wrong somewhere in the world unless it names the authority. A figure that sits comfortably inside the European limit can sit at three times the American one.

Heat Stability: A Genuine Disagreement

Sucralose is widely described as heat stable and therefore suitable for baking. FDA states this directly: it “is heat stable, meaning it stays sweet even when used at high temperatures during baking, making it suitable as a sugar substitute in baked goods.”

EFSA, assessing a proposed extension of sucralose into fine bakery wares in the same re-evaluation, reached a different position: “the Panel could not conclude on the safety of the proposed extension of use of E 955 in this food category.” The stated reason was uncertainty about the formation of chlorinated compounds across the diverse range of real baking processes — while noting that the controlled studies available showed no significant increases in 3-MCPD or dioxin-type compounds.

These are not quite the same question. FDA is describing whether sucralose remains sweet when heated; EFSA is assessing what may form when it is. Both matter to anyone formulating a baked product, which is why this page carries both rather than the more convenient one. As of this review, the EU extension into fine bakery wares has not been cleared.

Energy, Blood Glucose and What Is Actually in the Packet

Pure sucralose is used in milligram quantities and contributes no meaningful calories or carbohydrate, and it does not raise blood glucose directly the way sugar does.

What you buy is usually not pure sucralose. Retail packets and cup-for-cup baking blends are bulked with dextrose or maltodextrin to make a milligram of sweetener into something you can measure with a spoon. Both are ordinary, rapidly digested carbohydrate. A sucralose packet is therefore not a zero-carbohydrate product; the sucralose inside it is. Read the ingredient panel and the serving size, not the front of the box — this is the same trap that applies to stevia and monk fruit products.

Recent Metabolic Research

A 2025 randomized crossover study in Nature Metabolism gave 75 adults — spanning healthy weight, overweight and obesity — a drink containing sucralose, a sweetness-matched sucrose drink, or water. Compared with sucrose, sucralose increased blood flow in the hypothalamus and produced greater hunger ratings. Compared with water, sucralose still increased hypothalamic blood flow but produced no difference in hunger.

That second comparison is routinely dropped in coverage of this study, and it changes the interpretation considerably. The finding is an acute, mechanistic one about brain response and short-term appetite signalling. It is not a weight outcome, not a disease outcome, and not evidence that sucralose causes weight gain. Separate short-term work has reported changes in insulin sensitivity and gut microbiome measures over 30 days, while a 2025 meta-analysis of artificially sweetened beverages found no significant overall metabolic-risk effect. The evidence across trial, beverage and observational designs is genuinely mixed, partly because dose, comparator, prior consumption and product formulation differ so much between studies.

Typical Food Uses

Sucralose appears in tabletop sweeteners, diet soft drinks and flavoured beverages, chewing gum, gelatins, frozen dairy desserts, baked goods, and a wide range of reduced-sugar packaged foods. Its stability in acidic beverages over long shelf lives is a large part of why it became so widespread in soft drinks.

Comparison Note

Sucralose has the most robust regulatory paperwork on this site and the least settled metabolic story. Against stevia, which has a single internationally agreed ADI and a plant origin many buyers prefer, sucralose offers greater heat stability in beverages and a cleaner sweetness profile without stevia’s licorice-like tail. Against the bulk sweeteners — erythritol, xylitol, allulose — it provides no volume, structure or browning at all, so it is a component in a formulation rather than a replacement for sugar.

It is an effective tool for reducing sugar and calories when it replaces sugar rather than being added alongside it. It should not be described as proven metabolically inert in every person, and regulatory approval is not evidence of long-term health benefit — those are separate questions, and only the first has been answered.